Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;34(7):1670-1677.
doi: 10.1002/ptr.6639. Epub 2020 Feb 21.

Quality of Life, Mental Health, Personality and Patterns of Use in Self-Medicated Cannabis Users with Chronic Diseases: A 12-Month Longitudinal Study

José C Bouso  1 , Daniel Jiménez-Garrido  1 , Genís Ona  1   2 , Damian Woźnica  1 , Rafael G Dos Santos  1   3   4 , Jaime E C Hallak  3   4 , Beatriz A P B Paranhos  5 , Felipe de Almeida Mendes  5 , Mauricio Yonamine  5 , Miguel Á Alcázar-Córcoles  6 , Magí Farré  7   8
Affiliations

Quality of Life, Mental Health, Personality and Patterns of Use in Self-Medicated Cannabis Users with Chronic Diseases: A 12-Month Longitudinal Study

José C Bouso et al. Phytother Res. 2020 Jul.

Abstract

The number of patients using cannabis for therapeutic purposes is growing worldwide. While research regarding the treatment of certain diseases/disorders with cannabis and cannabinoids is also expanding, only a few longitudinal studies have assessed the mid-term impacts of medical cannabis use on psychological variables and quality of life (QoL). The aim of the study was to assess the psychological safety and QoL of patients with chronic diseases who self-medicate with cannabis over time. We recruited patients with various chronic diseases who use cannabis and collected data regarding patterns of cannabis use as well as mental health, personality and QoL. Participants were followed-up at baseline, 4, 8 and 12 months. Hair analysis was conducted to confirm the presence of cannabinoids. Personality assessment showed a consistent decrease in self-transcendence and self-directedness scores. Neither cognitive nor psychopathological deterioration was found. There were also no variations in QoL. Mid-term use of medical cannabis seems to show adequate tolerability regarding cognitive and psychopathological abilities, and it may help patients with chronic diseases to maintain an acceptable QoL.

Keywords: cannabis; chronic disease; medical cannabis; mental health; quality of life.

PubMed Disclaimer

References

REFERENCES

    1. Aixalà, M., Ona, G., Parés, Ò., & Bouso, J. C. (2019). Patterns of use, desired effects, and mental health status of a sample of natural psychoactive drug users. Drugs Educ Prevent Policy, 1-8. https://doi.org/10.1080/09687637.2019.1611739
    1. Alonso, J., Prieto, L., & Anto, J. M. (1995). La versión española del SF-36 Health Survey (Cuestionario de Salud SF-36): un instrumento para la medida de los resultados clínicos. Med Clín (Barc), 104, 771.
    1. Amin, M. R., & Ali, D. W. (2019). Pharmacology of medical cannabis. Adv Exp Med Biol, 1162, 151-165.
    1. Bakas, T., McLennon, S. M., Carpenter, J. S., Buelow, J. M., Otte, J. L., Hanna, K. M., … Welch, J. L. (2012). Systematic review of health-related quality of life models. Health Qual Life Outcomes, 10(1), 1-12.
    1. Borras, R., Modamio, P., Lastra, C. F., & Marino, E. L. (2011). Medicinal use of cannabis in Spain. Altern Ther Health Med, 17(5), 52-54.